CD8A and Guillain-Barre syndrome: In line with observations in memory CD4+ T cells, the autoreactive memory CD8+ T cell response was mostly found in non-COVID-19 (four out of seven) rather than post-COVID-19 (one out of four) patients with GBS (Extended Data Fig. 3c).